One of the promising applications of alpha particles in nanotechnology is in targeted alpha therapy (TAT). In this approach, alpha-emitting isotopes are attached to nanoparticles that specifically bind to cancer cells. The localized emission of alpha particles can effectively kill cancer cells while minimizing damage to surrounding healthy tissue. This high degree of specificity and potency makes TAT a cutting-edge treatment option for certain types of cancers.
